1pm EDT (NA) / 6pm BST (UK) / 7pm CEST (EU-Central)

For years, diabetes clinical trials have been trailing clinical care because of regulatory and logistical challenges with utilizing CGMs in a clinical trial setting. But, because of recent FDA clearance of commercially available devices, these CGM devices have started to be implemented more widely in the clinical trial setting – at least in the United States – but global trials still present challenges.

In this webinar, our panel of clinical experts who specialize in the intersection of diabetes care and clinical trial technology will discuss the reasons why clinical trials are lagging behind current standard of care and share examples of how to overcome these challenges through emerging patient-centered technologies, innovative study design, and regulatory considerations.

Throughout this interactive panel discussion, our experts will provide insights based on their personal experience and share thoughts on how to align diabetes clinical trials with the current clinical standard of care to provide more accurate data and a better patient experience.

Key Learning Objectives:

• The ways in which diabetes clinical trials are lagging behind current standards of care and how patient-centered technology and innovative study design can bridge the gap
• The regulatory landscape that is leading to the shift towards patient-centered technologies such as continuous glucose monitors being utilized in diabetes clinical trials
• How understanding key study objectives and the value of specific data required dictates the technology you select and the level of time, effort, and money you must invest into the study
• How to utilize design thinking, patient-centered research to help design a diabetes study that will achieve these objectives, provide a better patient experience, and speed timelines
• Future opportunities for diabetes research to more closely align with clinical practice

Now available to watch on demand.